Subject category:
Strategy and General Management
Published by:
London Business School
Length: 11 pages
Data source: Published sources
Share a link:
https://casecent.re/p/21463
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is the first of a two-case series (302-062-1 and 302-063-1). This case focuses on the formation of Roslin BioMed, a spin-off from the Roslin Institute that was formed to commercialise the nuclear transfer technology behind the successful cloning of Dolly the sheep. The case describes the background to the birth of Dolly, and then follows the subsequent events - the establishment of Roslin BioMed, the recruitment of Simon Best as Chief Executive of the company, and his discussions with various partner companies.
Subject category:
Entrepreneurship
Published by:
London Business School
Length: 4 pages
Data source: Field research
Subject category:
Entrepreneurship
Published by:
London Business School
Length: 8 pages
Data source: Field research
About
Abstract
This is the first of a two-case series (302-062-1 and 302-063-1). This case focuses on the formation of Roslin BioMed, a spin-off from the Roslin Institute that was formed to commercialise the nuclear transfer technology behind the successful cloning of Dolly the sheep. The case describes the background to the birth of Dolly, and then follows the subsequent events - the establishment of Roslin BioMed, the recruitment of Simon Best as Chief Executive of the company, and his discussions with various partner companies.
Settings
Related
Subject category:
Entrepreneurship
Published by:
London Business School
Length: 4 pages
Data source: Field research
Subject category:
Entrepreneurship
Published by:
London Business School
Length: 8 pages
Data source: Field research